In patients with suspected immune TTP, admission source impacts hospital length of stay and time to therapeutic plasma exchange impacts clinical outcomes-Reference-Cited by-同舟云学术

In patients with suspected immune TTP, admission source impacts hospital length of stay and time to therapeutic plasma exchange impacts clinical outcomes

Published:2023-07 Issue: Volume:227 Page:34-39
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Soares Ferreira Junior Alexandre,Pinheiro Maux Lessa Morgana,Boyle Stephen H.,Sanborn Kate,Kuchibhatla Maragatha,Onwuemene Oluwatoyosi A.

Funder

American Society of Hematology

Publisher

Elsevier BV

Subject

Hematology

Reference17 articles.

1. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features;Scully;Br. J. Haematol.,2008

2. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies;Scully;Br. J. Haematol.,2012

3. Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019;J. Thromb. Haemost.,2022

4. Time from suspected thrombotic thrombocytopenic purpura to initiation of plasma exchange and impact on survival: a 10-year provincial retrospective cohort study;Sawler;Thromb. Res.,2020

5. Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era. Oury C;Van de Louw;PLoS ONE,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-novo immune-mediated thrombotic thrombocytopenic purpura following surgical and non-surgical procedures: A systematic review;Blood Reviews;2024-07

2. Therapeutic plasma exchange for sickle cell disease acute complications: A systematic review;Transfusion;2024-06-27

3. Distinguishing thrombotic thrombocytopenic purpura from primary immune thrombocytopenia accompanied by anemia using the carbon monoxide breath test;Hematology;2024-03-28

4. Paediatric patients with suspected immune thrombotic thrombocytopenic purpura also experience treatment delays;British Journal of Haematology;2024-01-04